[Antihyperglycemic treatment guidelines for diabetes mellitus type 2 (Update 2019)].

BORIS DOI
Publisher DOI
PubMed ID
30980148
Description
Hyperglycemia significantly contributes to complications in patients with diabetes mellitus. While lifestyle interventions remain cornerstones of disease prevention and treatment, most patients with type 2 diabetes will eventually require pharmacotherapy for glycemic control. The definition of individual targets regarding optimal therapeutic efficacy and safety as well as cardiovascular effects is of great importance. In this guideline we present the most current evidence-based best clinical practice data for healthcare professionals.
Date of Publication
2019-05
Publication Type
article
Subject(s)
600 - Technology::610 - Medicine & health
Keyword(s)
Diabetes mellitus Type 2 Glucose lowering Therapy
Language(s)
de
Contributor(s)
Clodi, Martin
Abrahamian, Heidemarie
Brath, Helmut
Brix, Johanna
Fasching, Peter
Föger, Bernhard
Francesconi, Claudia
Fröhlich-Reiterer, Elke
Harreiter, Jürgen
Hofer, Sabine E
Hoppichler, Friedrich
Huber, Joakim
Kaser, Susanne
Kautzky-Willer, Alexandra
Lechleitner, Monika
Ludvik, Bernhard
Luger, Anton
Mader, Julia K
Paulweber, Bernhard
Pieber, Thomas
Prager, Rudolf
Rami-Merhar, Birgit
Resl, Michael
Riedl, Michaela
Roden, Michael
Saely, Christoph H
Schelkshorn, Christian
Schernthaner, Guntram
Sourij, Harald
Stechemesser, Lars
Stingl, Harald
Toplak, Hermann
Wascher, Thomas C
Weitgasser, Raimund
Winhofer-Stöckl, Yvonne
Zlamal-Fortunat, Sandra
Additional Credits
Universitätsklinik für Angiologie
Series
Wiener klinische Wochenschrift
Publisher
Springer-Verlag
ISSN
0043-5325
Access(Rights)
open.access
Show full item